Is Rigid ICMR Eligibility Study Eligibility Criteria Impeding COVID-19 Convalescent Study Participation at India’s PGIMER Chandigarh?

Is Rigid ICMR Eligibility Study Eligibility Criteria Impeding COVID-19 Convalescent Study Participation at India’s PGIMER Chandigarh?

The prominent Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh struggles to find enough donors of convalescent plasma for its participation in an ongoing approved study for severe COVID-19 patients. Thus far, only five donors have come...
Beijing University Team Potent Convalescent Plasma-based Antibody Ready for Clinical Trials: Could Reduce COVID-19 Recovery Time

Beijing University Team Potent Convalescent Plasma-based Antibody Ready for Clinical Trials: Could Reduce COVID-19 Recovery Time

A Beijing University research team working “day and night” claims to have successfully tested a drug that could shorten the recovery time for patients infected with SARS-CoV-2, the virus behind the COVID-19 pandemic, hence offering a more near-term approach to...
How to Convert Doctors to Principal Investigators: Mayo Clinic’s National COVID-19 Convalescent Plasma Expanded Access Study

How to Convert Doctors to Principal Investigators: Mayo Clinic’s National COVID-19 Convalescent Plasma Expanded Access Study

Back in early April, TrialSite News received huge interest in a national COVID-19 Convalescent Plasma study titled “Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19” led by Michael Joyner of the Mayo Clinic. Upon our promotion of this...

Pin It on Pinterest